RNAseq of a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Ontology highlight
ABSTRACT: Our aims is correlate the data and classification of the subtype breast cancer obtained with the Pam50 assay with the data obtained from the analysis of the same patients RNAseq
ORGANISM(S): Homo sapiens
PROVIDER: GSE181466 | GEO | 2021/08/07
REPOSITORIES: GEO
ACCESS DATA